company background image
000739 logo

Apeloa PharmaceuticalLtd SZSE:000739 Stock Report

Last Price

CN¥13.96

Market Cap

CN¥16.1b

7D

0.4%

1Y

-20.6%

Updated

25 Jul, 2024

Data

Company Financials +

Apeloa Pharmaceutical Co.,Ltd

SZSE:000739 Stock Report

Market Cap: CN¥16.1b

000739 Stock Overview

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally.

000739 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Apeloa Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Apeloa PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥13.96
52 Week HighCN¥19.70
52 Week LowCN¥10.66
Beta-0.0063
11 Month Change2.87%
3 Month Change2.35%
1 Year Change-20.64%
33 Year Change-50.00%
5 Year Change37.81%
Change since IPO752.17%

Recent News & Updates

Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Jun 24
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 08
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Recent updates

Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Jun 24
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 08
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Shareholder Returns

000739CN PharmaceuticalsCN Market
7D0.4%-2.3%-2.9%
1Y-20.6%-17.7%-20.9%

Return vs Industry: 000739 underperformed the CN Pharmaceuticals industry which returned -17.7% over the past year.

Return vs Market: 000739 matched the CN Market which returned -20.9% over the past year.

Price Volatility

Is 000739's price volatile compared to industry and market?
000739 volatility
000739 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.1%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 000739 has not had significant price volatility in the past 3 months.

Volatility Over Time: 000739's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19897,208Chun Hewww.apeloa.com

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.

Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary

How do Apeloa PharmaceuticalLtd's earnings and revenue compare to its market cap?
000739 fundamental statistics
Market capCN¥16.12b
Earnings (TTM)CN¥1.06b
Revenue (TTM)CN¥11.59b

15.4x

P/E Ratio

1.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000739 income statement (TTM)
RevenueCN¥11.59b
Cost of RevenueCN¥8.83b
Gross ProfitCN¥2.76b
Other ExpensesCN¥1.70b
EarningsCN¥1.06b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 16, 2024

Earnings per share (EPS)0.91
Gross Margin23.81%
Net Profit Margin9.15%
Debt/Equity Ratio14.9%

How did 000739 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.